SCHEMBL16743567

SCHEMBL16743567

CC(C)C1C[C@H]2COC[C@@H](C1)N2C

nearest known ligand 0.31

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.31
CYP2C9 P11712 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15854046 1.00 LMNA (0.31) LMNACYP2C9
SCHEMBL11993155 1.00 LMNA (0.31) LMNACYP2C9
SCHEMBL15468906 1.00 LMNA (0.31) LMNACYP2C9
SCHEMBL15468882 0.82
SCHEMBL15030963 0.82
SCHEMBL14232024 0.82
SCHEMBL20756547 0.79 LMNA (0.42) LMNACYP2C9
SCHEMBL16387221 0.79
SCHEMBL15440801 0.77 SLC6A3 (0.37) CYP2C9
SCHEMBL803421 0.77 CYP2C9 (0.52) LMNACYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9598447-B2 Phosphorus-substituted quinoxaline-type piperidine compounds and uses thereof PURDUE PHARMA L.P. (US) 2017-03-21 US disclosed
US-9040533-B2 Oxime-substituted-quinoxaline-type piperidine compounds as ORL-1 modulators PURDUE PHARMA L.P. (US) 2015-05-26 US disclosed